TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2016

Paclitaxel, Ifosfamide, and Cisplatin Efficacy for First-Line Treatment of Patients With Intermediate- or Poor-Risk Germ Cell Tumors.

Darren R Feldman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.